AAV-mediated gene therapy improving mitochondrial function provides benefit in age-related macular degeneration models

Clin Transl Med. 2022 Aug;12(8):e952. doi: 10.1002/ctm2.952.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Dependovirus / genetics
  • Genetic Therapy*
  • Humans
  • Macular Degeneration* / genetics
  • Macular Degeneration* / therapy
  • Mitochondria / genetics